TRNS Stock Up 12% after 7-Day Win Streak

TRNS: Transcat logo
TRNS
Transcat

Transcat (TRNS) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 12% return. The company has gained about $101 Mil in value over the last 7 days, with its current market capitalization at about $850 Mil. The stock remains 13.8% below its value at the end of 2024. This compares with year-to-date returns of 9.5% for the S&P 500.

TRNS provides calibration, repair, inspection, maintenance, consulting services, and sells or rents test, measurement, and control instruments internationally. After this rally, is TRNS still a buy – or is it time to lock in gains? Deep dive with Buy or Sell TRNS.

Comparing TRNS Stock Returns With The S&P 500

The following table summarizes the return for TRNS stock vs. the S&P 500 index over different periods, including the current streak:
 

Relevant Articles
  1. Where Applied Materials Stock Is Most Exposed
  2. The Gross Margin Silence That Reshapes The Advanced Micro Stock Bull Case
  3. What If Amgen Stock’s Patent Worries Are Hiding Its Real Growth Engine?
  4. The Real Price Tag On Broadcom Stock Is Not What It Seems
  5. Amphenol Stock And The AI Guidance Wall Street Is Still Sizing Up
  6. The SLB Paradox: Short-Term Friction, Long-Cycle Fuel

Return Period TRNS S&P 500
1D 0.9% -0.4%
7D (Current Streak) 11.9% -0.5%
1M (21D) 8.4% 0.8%
3M (63D) -0.1% 11.0%
YTD 2025 -13.8% 9.5%
2024 -3.3% 23.3%
2023 54.3% 24.2%
2022 -23.3% -19.4%

 
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has TRNS behaved after prior drops? See TRNS Dip Buyer Analysis to learn more.

Gains and Losses Streaks: S&P 500 Constituents

There are currently 33 S&P constituents with 3 days or more of consecutive gains and 35 constituents with 3 days or more of consecutive losses.
 

Consecutive Days # of Gainers # of Losers
3D 16 29
4D 11 3
5D 3 3
6D 3 0
7D or more 0 0
Total >=3 D 33 35

 
 
Key Financials for Transcat (TRNS)

Last 2 Fiscal Years:

Metric FY2024 FY2025
Revenues $259.5 Mil $278.4 Mil
Operating Income $19.8 Mil $17.9 Mil
Net Income $13.6 Mil $14.5 Mil

Last 2 Fiscal Quarters:

Metric 2025 FQ4 2026 FQ1
Revenues $77.1 Mil $76.4 Mil
Operating Income $6.9 Mil $5.3 Mil
Net Income $4.5 Mil $3.3 Mil

 
While TRNS stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.